PIK3CA and head and neck cancer: Importantly however, recent comprehensive genomic approaches have revealed a high prevalence of mutations in members of the PI3K pathway in various human cancer types, including head and neck cancer (HNC), breast cancer, or endometrial carcinoma [13–15].